I don't know really. It seems like we can move very quickly in both directions, so I don't think we'll be having to wait that long given the company's direct language around the licensing, or more likely, Acquistion of the company. It is possible we could get that outstanding offer Pre-Phase 3 but I think it will come after Phase 3 top line data, but well before approval and even a NDA being submitted so the timelines aren't really that long. This completely ignores any positive developments for Daybue could have on our SP. I have feeling that Catherine's estimate for 2025 is conservative and the sales team investments will yield some results, but our share price reflect pure negativity and not much else.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)